Belite Bio
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Belite Bio generated cash of -$29,837,000, which is less than the previous year. Cash used in financing activities reached the amount of $75,959,000 last year. Net change in cash is therefore $46,068,000.
Cash Flow
| 2020 | -4.44M | -20K | 28.05M |
|---|---|---|---|
| 2021 | -7.47M | -56K | -583K |
| 2022 | -11.45M | -394K | 36.96M |
| 2023 | -29.83M | -63K | 75.95M |
BLTE Cash Flow Statement (2020 – 2023)
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
Cash at beginning of period | 42.08M | 17.34M | 25.61M | 2.01M |
Operating activities | ||||
Net income | -31.63M | -12.64M | -9.66M | -5.75M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||
Depreciation and amortization | 399K | 198K | 30K | 17K |
Stock-based compensation expense | 3.82M | 1.48M | 1.53M | 1.36M |
| Deferred income tax benefit | 3.82M | 1.48M | 1.53M | 1.36M |
| Changes in operating assets and liabilities: | ||||
Accounts receivable, net | -72K | -32K | 0 | 4K |
Inventories | 0 | 0 | 0 | 0 |
Accounts payable | 0 | 0 | 0 | 0 |
Cash generated by operating activities | -29.83M | -11.45M | -7.47M | -4.44M |
Investing activities | ||||
Purchases Of Investments | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -63K | -394K | -74K | -20K |
Acquisitions Net | 0 | 0 | 18K | 0 |
Cash generated by investing activities | -63K | -394K | -56K | -20K |
Financing activities | ||||
Common Stock Issued | 77.18M | 37.99M | -583K | 500K |
Payments for dividends | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | -2.45M |
Cash used in financing activities | 75.95M | 36.96M | -583K | 28.05M |
Net Change In Cash | 46.06M | 24.74M | -8.27M | 23.60M |
Cash at end of period | 88.15M | 42.08M | 17.34M | 25.61M |
| Data source | Data source |